(Q44381033)

English

Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis

scientific article published in April 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

steatohepatitis

0 references

0 references

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

non-alcoholic steatohepatitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Craig A Sponseller

4

object named as

Craig A Sponseller

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Elizabeth M. Brunt

2

object named as

Elizabeth M Brunt

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

Brent A Neuschwander-Tetri

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Kent R Wehmeier

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Karen Hampton

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Bruce R Bacon

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

publication date

1 April 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Journal of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

434-440

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Role of Hyperinsulinemia and Glucose Intolerance in the Pathogenesis of Nonalcoholic Fatty Liver in Patients with Normal Body Weight

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The relationship between fatty liver and hyperinsulinemia in obese Japanese children.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of nonalcoholic fatty liver disease with insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Fatty liver--an additional and treatable feature of the insulin resistance syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic subcapsular steatosis in a patient with insulin dependent diabetes receiving dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver pathology and the metabolic syndrome X in severe obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperinsulinemia and insulin resistance in non-alcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin resistance in non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperinsulinemia in nondiabetic, both obese and nonobese patients with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Orphan nuclear receptors: shifting endocrinology into reverse

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Troglitazone-induced hepatic failure leading to liver transplantation. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Updated definitions of healthy ranges for serum alanine aminotransferase levels

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic failure in a patient taking rosiglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocellular injury in a patient receiving rosiglitazone. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocellular injury in a patient receiving pioglitazone.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of abdominal fat accumulation and liver steatosis: importance of ultrasonographic and anthropometric measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic correlates of eating behavior in severe obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900027-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(03)00027-8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44381033&oldid=2020641790"